⭐ Worth Watching

High-impact BSE & NSE announcements curated by AI scores — past 30 days, one per company

⭐ FeaturedNSEPress Release▲ PositiveExpansion26 Oct 2026

Sudeep Pharma Limited

Press Release

Sudeep Pharma Limited has received FDA approval for its new pharma greenfield manufacturing facility at 179 Nandesari, Gujarat, enabling the commencement of manufacturing operations. The facility has an annual installed capacity of 51,200 MT, strengthening manufacturing capabilities across Pharma, Food & Nutrition and Specialty Ingredients.

⭐ FeaturedNSEGeneral Updates▲ PositiveResults26 Oct 2026

Skyways Air Services Limited

General Updates

Skyways Air Services Limited has informed the Exchange that it has strengthened its international cargo leadership with a 6.3% market share in Q2 FY27, up from 6.2% in the preceding quarter, and advanced to 42nd globally.

⭐ FeaturedBSECompany Update▲ PositiveOrder Win26 Oct 2026

Biocon Ltd

Company Statement

Biocon Ltd has secured market entry for its proposed biosimilar to Stelara, Yesintek, in additional global markets, including Australia, Brazil, China, Hong Kong, Israel, Mexico, New Zealand, South Korea, and Kazakhstan.

⭐ FeaturedNSEInvestor Presentation▲ PositiveResults24 Oct 2026

Panache Digilife Limited

Investor Presentation

Panache Digilife Limited has informed the Exchange about Investor Presentation for Q2 FY27, with a strong performance in revenue and EBITDA growth, and a significant order in the telecom sector.

⭐ FeaturedBSECompany Update▲ PositiveResults24 Oct 2026

Modis Navnirman Ltd

Pursuant to the relevant provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby submit the Investor Presentation for the Q2 & H1 of FY 2026-27, for the quarter and half year ended September 30, 2026.

Modis Navnirman Ltd has reported a strong H1 FY27 performance with revenue growth of 53% YoY, EBITDA increase of 63% YoY, and PAT rise of 59% YoY. The company has also added a new redevelopment project to its development pipeline.

⭐ FeaturedBSECompany Update▲ PositiveResults24 Oct 2026

Lumax Auto Technologies Ltd

Investor Release of Financial Results for the 2nd Quarter and Half Year ended September 30, 2026.

Lumax Auto Technologies Ltd reported a 35% YoY revenue growth in Q2FY27, crossing ₹1,500 crore, and 34% YoY revenue growth in H1FY27 to ₹2,919 crore, driven by technology-led expansion, portfolio diversification, and operational excellence. EBITDA grew 34% YoY in Q2FY27 and 42% YoY in H1FY27, with margins at 14.7% and 14.9% respectively. PAT before minority interest grew 50% YoY in Q2FY27 and 64% YoY in H1FY27.

⭐ FeaturedBSECompany Update▲ PositiveResults24 Oct 2026

IDFC First Bank Ltd

Press Release- Financial Results for the quarter and half year ended September 30, 2026.

IDFC First Bank Ltd reported a 196.5% YoY increase in Profit After Tax to ₹1,045 crore in Q2 FY27, with PAT crossing ₹1,000 crore for the second consecutive quarter. The Bank's Return on Assets stood at 0.99% in H1 FY27. Strong deposit growth, healthy CASA, and loan growth were key highlights. The Bank also mobilised ₹34,390 crore of FCNR(B) deposits, providing structural liquidity for the coming years.

⭐ FeaturedNSEGeneral Updates▲ PositiveMgmt Change24 Oct 2026

Apollo Micro Systems Limited

General Updates

Apollo Micro Systems Limited has informed the Exchange about General Updates, including a letter to shareholders from the Managing Director, highlighting the company's performance in Q2 and H1 FY27, and its commitment to building indigenous defence capabilities.

⭐ FeaturedNSEPress Release▲ PositiveOrder Win24 Oct 2026

Orchid Pharma Limited

Press Release

Orchid Pharma Limited has entered into a licensing and supply agreement with Laboratorio Libra S.A. for Exblifep (Cefepime/Enmetazobactam) across nine Latin American markets, with a potential commercial opportunity of approximately USD 80 million over the first 10 years.

⭐ FeaturedNSEPress Release▲ PositiveResults24 Oct 2026

Cubex Tubings Limited

Press Release

Cubex Tubings Limited reported strong Q2 FY27 financial results, with EBITDA up 119% YoY to ₹7.2 crore at an 8.6% margin, and profit after tax up 162% YoY. The company secured orders aggregating ₹33Cr during H1 FY27 across multiple sectors, reflecting strong business momentum and sustained demand for its offerings.

⭐ FeaturedNSECredit Rating▲ PositiveRating Change24 Oct 2026

ICICI Bank Limited

Credit Rating

ICICI Bank Limited has informed the Exchange about Credit Rating reaffirmed by ICRA and CARE Ratings for its various facilities/instruments. ICRA has reaffirmed the credit ratings of ICICI Bank Limited's Facilities/Instruments. The ratings continue to be supported by its strong position as one of the three systemically important banks in India, reflected by its sizeable market share in banking sector advances. The ICICI Group has a presence across different verticals in the financial services sector, which has driven the growth of its granular assets and liabilities. The ratings also factor in the bank's strong capitalisation profile, with the common equity Tier I (CET I) ratio remaining healthy at 16.01% of risk-weighted assets (RWAs) as on Sep 30, 2026.

← PreviousPage 28 of 125Next →